期刊文献+

含氧叔丁基三唑醇类化合物的合成及其体外抗真菌活性

Synthesis and antifungal activities of 1-(1H-1,2,4-triazol-1-yl)-2-(t-butyl)-3-(O-substituted)-2-propanols
下载PDF
导出
摘要 目的设计合成含氧取代的叔丁基三唑醇类化合物并研究其体外抗真菌活性。方法以一氯频那酮为起始原料经多步反应合成目标化合物,化合物结构经1H-NMR谱、IR谱确证;选择8种真菌为实验菌株,按国际标准抗真菌敏感性实验方法测定体外抑菌活性。结果与结论合成了12个新化合物。所有目标化合物对8种真菌均具有一定的抑制作用。可以将现有的三唑醇类抗真菌药物结构中的2,4-二氟苯基替换成其他疏水性基团来设计抗真菌化合物。 Aim To study the antifungal activities of triazole derivatives bearing tert-butyl group and to compare their antifungal activities with that of the control drugs fluconazole and itraconazole. Methods Twelve target compounds were designed by the replacement of 2, 4-difluorophenyl group with tert-butyl moiety, The target compounds were confirmed by ^1H-NMR and IR. The MIC80 of all the target compounds were determined by the method recommended by the national committee for clinical laboratory standards (NCCLS) using the RPMI 1640 test medium. Results and conclusion All the target compounds were firstly reported. The results of the preliminary antifungal test show that all the target compounds exhibit potent antifungal activities to a certain extent. Other hydrophobic moieties besides 2, 4-difluorophenyl group can be introduced to design triazole compounds.
出处 《中国药物化学杂志》 CAS CSCD 2007年第4期204-208,共5页 Chinese Journal of Medicinal Chemistry
基金 国家自然科学基金项目(20672140) 全军医药卫生科研基金项目(01MA156)
关键词 叔丁基 三唑醇 一氯频那酮 抗真菌活性 t-butyl triazolol chloromethyl t-butyl ketone antifungal activity
  • 相关文献

参考文献8

  • 1GUNSILIUS E,LASS-FLORL C,KAHLER C M.Candida ciferrii,a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients[J].Ann Hematol,2001,80(3):178-179.
  • 2MARTIN M V.The use of fluconazole and itraconazole in the treatment of Candida albicans infections:a review[J].J Antimicrob Chemother,1999,44 (4):429-437.
  • 3JOHNSON L B,KAUFFMAN C A.Voriconazole:a new triazole antifungal agent[J].Infect Dis,2003,36(5):630-637.
  • 4AGRAWAL A K,SHERMAN L K.Voriconazole-induced musical hallucinations[J].Infection,2004,32(5):293-295.
  • 5何秋琴,刘超美,门秀峰,赵靖霞.叔丁基三唑衍生物的合成及抗真菌活性研究[J].中国药物化学杂志,2005,15(5):262-265. 被引量:13
  • 6GOLLAPUDY R,AJMANI S,KULKARNI S A.Modeling and interactions of Aspergillus fumigatus lanosterol 14-α demethylase A with azole antifungals[J].Bioorg Med Chem,2004,12(11):2937-2950.
  • 7HOLMWOOD G,REGEL E.Substituted triazolylmethyl-oxiranes and their use as intermediates for fungicides,US:4499281[P].1985-02-12.
  • 8LOGU A D,SADDI M,CARDIA M C,et al.In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp.and fluconazole-resistant Candida albicans[J].Antimicrob Agents Chemother,2005,55 (5):692-698.

二级参考文献8

  • 1Gunsilius E,Lass-Flrl C,Khler CM.Candida ciferrii,a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients[J].Ann Hematol,2001,80(3):178-179.
  • 2Martin MV.The use of fluconazole and itraconazole in the treatment of Candida albicans infections:a review[J].J Antimicrob Chemother,1999,44(4):429-437.
  • 3Johnson LB,Kauffman CA.Voriconazole:a new triazole antifungal agent[J].Infect Dis,2003,36(5):630-637.
  • 4Agrawal AK,Sherman LK.Voriconazole-induced musical hallucinations[J].Infection,2004,32(5):293-295.
  • 5Reiser W,Draber W,Buechel KH,et al.1-Vinyltriazole compounds and plant growth and fungicidal compositions[P].US:4486218,1984-12-04.
  • 6Holmwood G,Regel E.Substituted triazolylmethyl-oxiranes and their use as intermediates for fungicides[P].US:4499281,1985-02-12.
  • 7Logu AD,Saddi M,Cardia MC,et al.In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp.and fluconazole-resistant Candida albicans[J].J Antimicrob Chemother,2005,55(5):692-698.
  • 8季海涛,张万年,周有骏,朱杰,朱驹,吕加国.氮唑类抗真菌药物药效构象及其与酶活性位点对接[J].药学学报,1999,34(4):280-285. 被引量:15

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部